baber/WOPTO huggingface dataset:
Patent AU-2021277366-A1 (AU)
Title: Port status configuration method, apparatus,and system, and storage medium
Inventor: LV JINGFEI
IPC: H04J3/06
Filed: 2021-05-18
Abstract: The present application discloses a port state configuration method, an apparatus, a system and a storage medium, belonging to the field of communications. Said method comprises: a configuration device acquiring port data sets of M ports in N converters, N being an integer greater than 1, and M being an integer greater than 1, the N converters being integrated into at least two independent devices, the M ports being M precision time protocol ports, and the port data sets being precision time protocol port data sets; and the configuration device configuring the port state of the M ports according to the port data sets of the M ports, the port state being a precision time protocol port state. The present application achieves automatic configuration of a port state and improves configuration accuracy.
Patent AU-2021287250-A1 (AU)
Title: Systems, devices, and methods for improved analyte sensor accuracy and fault detection
Inventor: BUDIMAN ERWIN S
IPC: A61B5/145
Filed: 2021-06-07
Abstract: Various embodiments of systems, devices and methods for improving the accuracy of an analyte sensor and for detecting sensor fault conditions are disclosed. According to some embodiments, these systems, devices, and methods can utilize a first data collected by a glucose sensor and a second data collected by a secondary sensing element. In some embodiments, the secondary sensing element can be one of a lactate sensing element, a ketone sensing element, or a heart rate monitor, among others.
Patent AU-2021319440-A1 (AU)
Title: Calcium-deficient silicate-substituted calcium phosphate apatite compositions and methods
Inventor: GIBSON IAIN
IPC: C01B25/32
Filed: 2021-08-06
Abstract: A calcium-deficient silicate-substituted calcium phosphate apatite composition comprises an apatite phase having a Ca/P molar ratio of from greater than 2.15 to 2.30, and a Ca/(P+Si) molar ratio of from 1.45 to 1.55. A method of producing a calcium-deficient silicate-substituted calcium phosphate apatite composition comprises contacting a silicate-substituted calcium phosphate apatite starting material with an acidic solution to produce the calcium-deficient silicate-substituted calcium phosphate apatite composition. The starting material comprises an apatite phase and up to 15 wt% total of a phase or phases other than the apatite phase, and has a Ca/P molar ratio of from 2.3 to 2.6, and a Ca/(P+Si) molar ratio of from 1.56 to 1.66, and the calcium-deficient silicate-substituted calcium phosphate apatite composition comprises an apatite phase having a Ca/P molar ratio lower than the Ca/P ratio of the starting material apatite phase.
Patent AU-2021340274-A1 (AU)
Title: Improvements in or in relation to sugarcane processing
Inventor: FITZMAURICE ALAN LEWIS
IPC: C13B10/02
Filed: 2021-09-08
Abstract: A slotted conveyor floor 16 in milling tandem, slots 34 extend across the direction of liquid flow shown by arrow 35 which is against the flow of fibre. The slots are cut through the material of floor 16 on the vertical as depicted by centre-line 35 taken relative to the inclination of floor 16. Thus the centre-line corresponds to gravity feed for the liquid. Rather than being directly across the floor 16, the slots are inclined in the direction of flow. The fibre is in the opposite flow relation to the liquid, in this example, the slots are across the line of the fibre and are about 6mm wide and 180mm long with about 60mm spacing. Adjacent lines of slots are set interdigital in the direction of travel. This arrangement minimises fibre being trapped in the slots as the fibre is being carried by the rakes up the floor.
Patent AU-2021374235-A1 (AU)
Title: Tilt bucket assembly for an excavator
Inventor: FREY STEVEN OSCAR
IPC: E02F3/40
Filed: 2021-10-21
Abstract: An assembly for an excavator includes a bucket having coupling flanges spaced apart from each other. The coupling flanges extend upwardly from a top wall of the bucket and laterally between side plates of the bucket. Each coupling flange has an aperture. The assembly also includes a linkage assembly coupled to the bucket and configured to tilt the bucket relative to an arm of the excavator. The linkage assembly includes: a top mount configured to be fixedly releasably coupled to the arm of the excavator; a shaft fixedly coupled to the top mount and received in each of the apertures such that the bucket is pivotally coupled to the shaft; a drive lug coupled to and depending from the shaft between the coupling flanges; and a linear actuator coupled to the bucket and the drive lug to pivot the bucket about the shaft.
Patent AU-2021379692-A1 (AU)
Title: Tablet for use in treating huntington's disease and method of making the same
Inventor: PINNAMANENI SWATHI
IPC: A61K9/20
Filed: 2021-11-12
Abstract: The present description relates to a tablet formulation of 2-[3-(2,2,6,6- tetramethylpiperidin-4-yl)-3H-[l,2,3]triazolo[4,5-c]pyridazin-6-yl]-5-(2H-l,2,3-triazol-2- yl)phenol, a compound for use in treating Huntington's disease, and a method of making the same.
Patent AU-2021398261-A1 (AU)
Title: Macrophage activator
Inventor: INUI TOSHIO
IPC: A61K38/16
Filed: 2021-12-08
Abstract: The present invention provides a macrophage activator comprising Gc protein by a simple process. This macrophage activator comprises Gc protein to which no N-acetylgalactosamine is attached.
Patent AU-2021404152-A1 (AU)
Title: Ligand-binding polypeptides and uses thereof
Inventor: HOWARTH MARK
IPC: C07K14/81
Filed: 2021-12-15
Abstract: The present invention relates to polypeptides that are resistant to degradation in the gastrointestinal tract and that bind to a target (i.e. a target ligand). In particular, it provides a mutant Kunitz-type soybean trypsin inhibitor (SBTI) family polypeptide comprising two or more amino acid mutations compared to the corresponding unmutated (e.g. wild-type) SBTI family polypeptide, wherein the mutant SBTI family polypeptide comprises: (i) one or more amino acid mutations in a first domain corresponding to positions 22-25 of SEQ ID NO: 1; and (ii) one or more amino acid mutations in a second domain corresponding to positions 47-50 of SEQ ID NO: 1, wherein the mutant SBTI family polypeptide: (a) binds selectively to a ligand that does not bind to the corresponding unmutated (e.g. wild-type) SBTI family polypeptide; and (b) is resistant to cleavage by pepsin.
Patent AU-2021427262-A1 (AU)
Title: Conjugation device and method for producing conjugates
Inventor: QIN GANG
IPC: A61K47/64
Filed: 2021-04-14
Abstract: A conjugation device includes at least one flow reactor (10) having an inlet (101) and an outlet (102), the flow reactor (s) being completely filled with a support such as a matrix including 1) chromatography beads, fibers or membranes, and 2) a biologic catalyzer, namely the enzyme ligase, which is immobilized onto this support; a fluid delivery unit (11) in fluid communication with the inlet (101) of the flow reactor (s) and configured to continuously provide the flow reactor (s) with at least one kind of reaction fluid such as antibody and linker-payload according to stages of the conjugation process, the at least one kind of process fluid including a first moiety and a second moiety of a conjugate to be produced; and a fluid collection unit (12) in fluid communication with the outlet (102) of the flow reactor (s) and configured to control collection of fluid flowing out of the outlet of the flow reactor (s) according to the stages of the conjugation process. In a period of enabling the at least one kind of reaction fluid to continuously flow through the flow reactor (s), a conjugation reaction is conducted between the first moiety and the second moiety under catalysis of the ligase to produce the conjugate.
Patent AU-2022201049-A1 (AU)
Title: Intelligent appointment suggestions
Inventor: JON TIFFANY S
IPC: G06Q10/10
Filed: 2022-02-17
Abstract: Some embodiments provide a method for automatically generating an appointment for an 
electronic calendar. The method receives input to create a new appointment for the calendar.  
The method analyzes several previous appointments stored for the first calendar. Based on 
the analysis, the method automatically proposes a new appointment that has at least one 
appointment characteristic shared with at least one past appointment stored for the calendar.  
In some embodiments, the method receives text input describing a characteristic of the new 
appointment, and searches through the previous appointments using the text input.
Patent AU-2022203452-A1 (AU)
Title: Bean variety svgg1312
Inventor: OPPELAAR ARIE
IPC: A01H6/54
Filed: 2022-05-20
Abstract: OF THE DISCLOSURE 
The invention provides seed and plants of the bean line SVGG1312. The invention 
thus relates to the plants, seeds, and tissue cultures of bean line SVGG1312 and to methods 
for producing a bean plant produced by crossing a plant of bean line SVGG1312 with itself or 
with another bean plant, such as a plant of another genotype. The invention further relates to 
seeds and plants produced by such crossing. The invention further relates to parts of a plant 
of bean line SVGG1312, including the pods and gametes of such plants.  
18737334_1 (GHMatters) P119049.AU
Patent AU-2022212142-A1 (AU)
Title: Use of composition containing vinpocetine in cerebrovascular diseases
Inventor: HUA YAO
IPC: A61K31/4709
Filed: 2022-01-26
Abstract: Disclosed is the use of a composition containing vinpocetine or a pharmaceutically acceptable salt thereof and edaravone in the preparation of a drug for treating cerebrovascular diseases, especially ischemic cerebrovascular diseases. The experiment result shows that the tail vein administration of 1-15 mg/kg of vinpocetine or 1.67-8.33 mg/kg of edaravone on rats with a focal cerebral ischemia-reperfusion injury can significantly ameliorate neurological defects in rats with an MCAO and reduce a cerebral infarction area; and performing compound combination within the dosage range (the mass ratio of vinpocetine : edaravone is 1 : 5 to 5 : 1) can be synergistic. The tail vein administration of 3.33-16.67 mg/kg of vinpocetine or 3.33-16.67 mg/kg of edaravone on mice with a focal cerebral ischemia-reperfusion injury can significantly ameliorate neurological defects in mice with an MCAO and reduce a cerebral infarction area.
Patent AU-2022218521-A1 (AU)
Title: Generating channel access patterns for networks that are not coordinated with one another
Inventor: OBERNOSTERER FRANK
IPC: H04B1/7156
Filed: 2022-08-17
Abstract: Embodiments relate to a controller for a participant of a communications system, 
wherein the communications system wirelessly communicates in a frequency band which is 
5 used by a plurality of communications systems for communication, wherein the controller is 
designed to determine a channel access pattern, wherein the channel access pattern specifies 
a frequency- and/or time-hop-based allocation of the frequency band which can be used for the 
communication of the communications system, wherein the controller is designed to determine 
the channel access pattern according to individual information of the communications system 
10 and according to a status of a number sequence generator for generating a number sequence 
or a number of a number sequence.
Patent AU-2022220014-A1 (AU)
Title: Bra with intermediary flexible layer and method for manufacturing same
Inventor: SUESS EMILY
IPC: A41C3/00
Filed: 2022-02-14
Abstract: A bra and method of manufacturing the same that is designed to (1) provide the optimum level of support, comfort, fit and coverage to a wearer of the bra, (2) visually enhance the wearer's figure by preventing cup gaping and side and top overflow or bulging, and (3) improve the breathability of the bra, thereby reducing sweat and irritation of the skin on or around the wearer's breasts. The bra of the present disclosure comprises bra cups that include intermediary flexible layers that are configured such that they allow the bra cups to stretch and contract to accommodate and fit snugly around the wearer's breasts.
Patent AU-2022228364-A1 (AU)
Title: Engineered immune cell therapies
Inventor: ANGEL MATTHEW
IPC: C12N5/0783
Filed: 2022-03-04
Abstract: The present disclosure relates in part to engineered immune cells that are, inter alia, silenced from a host immune response.
Patent AU-2022229167-A1 (AU)
Title: Battery module with improved fire protection performance
Inventor: HONG SUNG-GOEN
IPC: H01M50/251
Filed: 2022-02-25
Abstract: Disclosed is a battery module which can effectively prevent the occurrence or spread of a fire. The battery module according to an aspect of the present invention comprises: a cell assembly comprising a plurality of secondary battery cells stacked together; and a module case having a lower plate, side plates, and an upper plate to form an inner space in which the cell assembly is accommodated, and including trap portions each formed in at least a part of the inner surface of each of the side plates to be concave outward.
Patent AU-2022239614-A1 (AU)
Title: Compounds for regulating trained immunity, and their methods of use
Inventor: JANSSEN HENRICUS MARIE
IPC: A61K31/335
Filed: 2022-03-18
Abstract: Provided herein are compounds of Formula (I), as well as compositions comprising a compound of Formula (I) and uses thereof.
Patent AU-2022254686-A1 (AU)
Title: System, method, and apparatus for tracking a tool via a digital surgical microscope
Inventor: POLCHIN GEORGE
IPC: A61B34/20
Filed: 2022-04-06
Abstract: The present disclosure relates generally to a system, method, and apparatus for tracking a tool via a digital surgical microscope. Cameras on the digital surgical microscope may capture a scene view of a medical procedure in real time, and present the scene view to the surgeon in a digitized video stream with minimal interference from the surgeon. The digital surgical microscope may process image data from each scene view in real time and use computer vision and machine learning models (e.g., neural networks) to detect and track one or more tools used over the course of the medical procedure in real-time. As the digital surgical microscope detects and tracks the tools, and responds accordingly, the surgeon can thus indirectly control, using the tools already in the surgeon's hands, various parameters of the digital surgical microscope, including the position and orientation of the robotic-arm-mounted digital surgical microscope.
Patent AU-2022263545-A1 (AU)
Title: A support
Inventor: TIANG OLIVER
IPC: E04H12/08
Filed: 2022-11-03
Abstract: A support for a roadside object, the support including: a hollow elongate body comprising: a first section 
having a plurality of first apertures separated by a first distance; and a second section having a plurality of 
second apertures separated by a second distance, wherein the first distance is different to the second 
distance.
WO 2017/100815 PCT/AU2015/050812 
1/3 
200 
13010 
140 
110 
-120 
150 
A B 300 
BjB 
A 
Figure 1
Patent AU-2022264378-A1 (AU)
Title: Regenerative bioactive suspension derived from freshly disaggregated tissue and methods of use in clinical therapies
Inventor: HOPKIN AMELIA
IPC: A61L27/54
Filed: 2022-04-20
Abstract: A bioactive suspension derived from freshly disaggregated tissue is provided, as well as related methods of formulation and use. The bioactive suspension may comprise a cell-free supernate derived from epidermal and dermal tissue that has been enzymatically and mechanically disaggregated, then separated, and which may contain tissue regeneration factors known to speed healing. The bioactive suspension may further comprise genetically-modified treatment cells, wild type cells, or both, and may be combined with one or more scaffolding elements to form a bioactive suspension combination product suitable for treatment of a cutaneous defect. Synthetic bioactive suspensions and bioactive suspension combination products are also provided.
Patent AU-2022267043-A1 (AU)
Title: Contact lenses for use in preventing or slowing the development or progression of myopia and related methods
Inventor: CHAMBERLAIN PAUL
IPC: G02C7/04
Filed: 2022-04-22
Abstract: A contact lens (101) for use in preventing or slowing the development or progression of myopia, and methods of manufacturing and using such a lens (101). The lens (101) includes an optic zone (102) and a peripheral zone (104) that has a variation in thickness configured to control rotation of the lens (101). The optic zone (102) comprises a central region (105) having a base power that focuses light from distant point objects to a distal focal surface, said light forming a blur circle as it passes through a proximal focal surface. An annular region (103) surrounding the central region (105), includes an add power region (107) spanning less than 75% of the annular region (103), and having an add power of 0.5 D or more. Points defining centres of curvature of the add power region form a segment of an annulus. The add power region (107) focuses light from distant point objects to form a focused arc at a proximal focal surface.
Patent AU-2022279648-A1 (AU)
Title: Method for synthesizing 9-aminomethyl tetracycline compounds
Inventor: CIRIANI MARINA
IPC: C07C231/12
Filed: 2022-05-26
Abstract: A method for synthesizing 9-aminomethyl tetracycline compounds is disclosed. The method comprises a) reacting minocycline and an hydroxymethylamide derivative to form a 2,9-(methylamide-substituted) minocycline and a 2-(methylamide-substituted) minocycline; b) reacting the 2,9-(methylamide-substituted) minocycline from step a) and an amine or diamine to form a 9-aminomethyl tetracycline intermediate; and c) reacting the 9-aminomethyl tetracycline intermediate from step b) and an aldehyde in the presence of a reducing agent to form a 9-aminomethyl tetracycline compound; or d) reacting the 9-aminomethyl tetracycline intermediate from step b) and an alkyl halide or an alkyl reagent to form a 9-aminomethyl tetracycline compound. Step b) may be operated in the absence of an hydrogenation reaction. The method may be a semi continuous or continuous flow process. Optionally, in a semi continuous flow process, two of steps a), b) and c) or d) may be carried without the use of batch reactors and without the need to isolate intermediate products between the reaction steps, for example steps b) and c) or steps b) and d) may operate in a continuous manner with the 9-aminomethyl tetracycline intermediate formed in step b) being used directly in step c) or d). The 9-aminomethyl tetracycline compound formed in step c) or d) may be omadacycline.
Patent AU-2022390711-A1 (AU)
Title: Method for preparing hydrogen from ammonia by using pressure swing adsorption
Inventor: AHN CHI-KYU
IPC: C01B3/04
Filed: 2022-11-10
Abstract: A method for preparing hydrogen from ammonia by using pressure swing adsorption (PSA) is provided. The method for preparing hydrogen from ammonia, of the present invention, comprises the steps of: generating hydrogen and nitrogen from ammonia gas through a high-temperature reaction by using a catalyst; performing purification by selectively adsorbing unreacted ammonia gas from a gas containing unreacted ammonia and low-purity hydrogen and nitrogen, which are supplied through the high-temperature reaction and cooled; and performing purification by separating high-purity hydrogen from the gas consisting of low-purity hydrogen and nitrogen, wherein purification is carried out by using a carbon molecular sieve (CMS) adsorbent so as to desorb the unreacted ammonia gas through PSA.
Patent AU-2023201947-A1 (AU)
Title: Exothermic transmutation method
Inventor: DE BELLIS GIUSEPPE
IPC: G21G1/10
Filed: 2023-03-30
Abstract: Exothermic transmutation method 
An exothermic transmutation method for at least partially deactivating radioactive 
material, the method comprising the steps of: 
- Arranging a dusty compound comprising at least a transition metal in a chamber (7) of a 
reactor (1) outside a closed container; 
- Arranging the radioactive material in said chamber (7), the radioactive material being 
and staying encapsulated in said closed container; 
- Providing hydrogen in contact with the dusty compound and with the radioactive 
material at a pressure higher than the ambient pressure; 
- Generating an electric field in the chamber (7), the electric field being applied to the 
dusty compound and the radioactive material; 
- Energizing the dusty compound by heating, then generating a transmutation of said at 
least one transition metal into another transition metal and proton emission towards the 
radioactive material, said radioactive material being at least partially deactivated, 
- Removing thermal energy from the reactor (1).
Patent AU-2023203500-A1 (AU)
Title: Computer graphics processing methods and systems for presentation of graphics objects or text in a wagering environment
Inventor: RICHES GUY IAIN OLIVER
IPC: A63F13/00
Filed: 2023-06-05
Abstract: Computer graphics processing systems and methods are provided for the 
presentation of graphic objects or text in a wagering environment. In at least one 
embodiment, the systems and methods present graphic objects on a graphic user 
interface screen that includes at least one of a plurality of betting lines, including a 
reference betting line, such as a market betting line having a value that corresponds 
to a value of a reference variable associated with an object, a high line having a 
value corresponding to an amount above the reference variable value, a low line 
having a value corresponding to an amount below the reference variable value, etc.  
The market, high, and low lines may be arranged spatially on the interface screen 
based at least on the values of each of the lines. The interface screen includes a 
least one computer generated graphic object associated with each of the betting 
lines that is selectable for submitting at least one of an up bet request and a down 
bet request. The at least one graphic object may be rotating or moving based on the 
tradeable state associated with the graphic object.
Patent AU-2023226698-A1 (AU)
Title: Oligonucleotide probes and uses thereof
Inventor: DOMENYUK VALERIY
IPC: C12N15/10
Filed: 2023-09-06
Abstract: Methods and compositions are provided to identify oligonucleotides that bind targets of interest.  
The targets include tissues, cells, circulating biomarkers such as microvesicles, including those 
derived from various diseases. The oligonucleotides can be used in diagnostic and therapeutic 
applications.
Patent WO-2020047620-A1 (WO)
Title: Generation of syngas for hydrogen production by steam reforming of hydrocarbons applying a process of complete combustion of a fuel gas stream in autothermal reforming
Inventor: TODOROV TODOR
IPC: C01B3/38
Filed: 2019-08-27
Abstract: The invention relates to the processes of steam reforming of hydrocarbons and of the partial or complete oxidation of hydrocarbons. The invention replaces the process of partial oxidation of the feed process gas in the conventional ATP by a process of complete combustion of a fuel gas stream. For the process of ATR with complete combustion, a fuel gas stream (11) separated after the Sulfur Removal Unit is fed into the combustion zone of the ATP reactor (16), mixed with a steam stream (12). A stream of oxidant (8), mixed with a steam stream (13), is also fed into the combustion zone. The complete combustion products deliver their heat by mixing with a (5) feed process gas and steam stream. The gas mixture enters the catalyst zone (16B) of the full combustion ATR reactor (16), where a steam reforming process of the hydrocarbons supplied by stream (5) (a process feed gas and steam mix) takes place.
Patent WO-2013006928-A1 (WO)
Inventor: DE CASTRI TEIXEIRA JUNIOR RODOLFO
IPC: H05K5/00
Filed: 2011-07-08
Abstract: The utility model patent for an external modem and pen drive protector is mainly aimed at protecting external modems and pen drives from possible accidents leading to loss of information contained in data relevant to the users. The manufacturers using this protector can add value and protection to their products, besides being able to place advertisements and other messages on the shallow relief top.